Company that offers OrganoPlates and develops human tissue and disease models.
MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
Visit website: https://mimetas.com/
Becoming Cyborg: 10 Amazing MedTech Inventions
Labiotech - 15-Dec-2015
Some of the best developments from 2015: Google contact lens with wireless chip and glucose sens...Read more...